Patents-Review.com
🔗 Permalink
Inventor profile of:

Thomas Wickham

City:

Groton, Massachusetts

Country:

United States

Published Applications:

28

Last publication date:

2024-03-28

Top Assignees for applications by Thomas Wickham

The entities that hold a legal rights for patent applications filed by inventor Wickham Thomas:

Recent patent applications by Wickham Thomas

Thomas Wickham from Groton, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-28
US20240101713A1
Chemistry; metallurgy

Bi-Specific Fusion Proteins

 #2 | 2023-10-12
US20230322951A1
Chemistry; metallurgy

Bi-Specific Fusion Proteins

 #3 | 2021-09-23
US20210290682A1
Human necessities

Functionalized Erythroid Cells

 #4 | 2021-07-15
US20210214463A1
Chemistry; metallurgy

Bi-specific fusion proteins

 #5 | 2021-02-11
US20210040233A1
Chemistry; metallurgy

Bi-specific fusion proteins

 #6 | 2020-02-13
US20200048368A1
Chemistry; metallurgy

Bi-specific fusion proteins

 #7 | 2018-08-23
US20180237540A1
Chemistry; metallurgy

Bi-specific fusion proteins

 #8 | 2017-11-23
US20170335015A1
Chemistry; metallurgy

Bi-specific fusion proteins

 #9 | 2017-09-14
US20170258903A1
Human necessities

COMBINATION THERAPIES FOR TREATING HER2-POSITIVE CANCERS THAT ARE RESISTANT TO HER2-TARGETED THERAPIES

 #10 | 2017-08-17
US20170231911A1
Human necessities

METHODS AND COMPOSITIONS FOR IMPROVING OUTCOMES OF LIPOSOMAL CHEMOTHERAPY

 #11 | 2017-07-06
US20170189335A1
Human necessities

DOSAGE AND ADMINISTRATION FOR PREVENTING CARDIOTOXICITY IN TREATMENT WITH ERBB2-TARGETED IMMUNOLIPOSOMES COMPRISING ANTHRACYCLINE CHEMOTHERAPEUTIC AGENTS

 #12 | 2017-04-27
US20170112950A1
Human necessities

Compositions and methods for non-invasive imaging

 #13 | 2017-03-23
US20170080087A1
Human necessities

Combination Therapies for Treating Her2-Positive Cancers that are Resistant to Her2-Targeted Therapies

 #14 | 2017-01-26
US20170022290A1
Chemistry; metallurgy

COMBINATION THERAPIES FOR TREATING HER2-POSITIVE CANCERS

 #15 | 2016-10-20
US20160303264A1
Human necessities

LIPOSOMES USEFUL FOR NON-INVASIVE IMAGING AND DRUG DELIVERY

 #16 | 2016-09-01
US20160250328A1
Human necessities

Combination therapy for treating HER2-positive cancers

 #17 | 2016-06-30
US20160184227A1
Human necessities

METHODS AND COMPOSITIONS FOR IMPROVING OUTCOMES OF LIPOSOMAL CHEMOTHERAPY

 #18 | 2016-06-16
US20160168269A1
Chemistry; metallurgy

Method of treating myocardial infarction by administering a bi-specific fusion protein

 #19 | 2016-03-10
US20160067182A1
Human necessities

METHODS AND COMPOSITIONS FOR IMPROVING OUTCOMES OF LIPOSOMAL CHEMOTHERAPY

 #20 | 2016-02-18
US20160045596A1
Human necessities

COMBINATION THERAPIES FOR TREATING HER2-POSITIVE CANCERS THAT ARE RESISTANT TO HER2-TARGETED THERAPIES

 #21 | 2016-02-11
US20160038417A1
Human necessities

Dosage and administration for preventing cardiotoxicity in treatment with ERbB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents

 #22 | 2016-02-11
US20160038416A1
Human necessities

DOSAGE AND ADMINISTRATION FOR PREVENTING CARDIOTOXICITY IN TREATMENT WITH ERBB2-TARGETED IMMUNOLIPOSOMES COMPRISING ANTHRACYCLINE CHEMOTHERAPEUTIC AGENTS

 #23 | 2015-04-02
US20150093328A1
Human necessities

Compositions and methods for non-invasive imaging

 #24 | 2014-06-26
US20140178380A1
Human necessities

Bi-specific fusion proteins

 #25 | 2014-01-23
US20140023698A1
Human necessities

Dosage and administration for preventing cardiotoxicity in treatment with ERBB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents

 #26 | 2011-12-01
US20110293579A1
Chemistry; metallurgy

Bi-specific fusion proteins

 #27 | 2011-11-24
US20110286976A1
Chemistry; metallurgy

Bi-specific fusion proteins for tissue repair

 #28 | 2010-12-30
US20100330029A1
Human necessities

Cancer Treatments with Radiation and Immunocytokines
InventorID:

622221 ⎘